These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3917 related articles for article (PubMed ID: 15709179)
1. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
2. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Smith JS; Alderete B; Minn Y; Borell TJ; Perry A; Mohapatra G; Hosek SM; Kimmel D; O'Fallon J; Yates A; Feuerstein BG; Burger PC; Scheithauer BW; Jenkins RB Oncogene; 1999 Jul; 18(28):4144-52. PubMed ID: 10435596 [TBL] [Abstract][Full Text] [Related]
3. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas. Watanabe T; Nakamura M; Kros JM; Burkhard C; Yonekawa Y; Kleihues P; Ohgaki H Acta Neuropathol; 2002 Mar; 103(3):267-75. PubMed ID: 11907807 [TBL] [Abstract][Full Text] [Related]
4. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas]. Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907 [TBL] [Abstract][Full Text] [Related]
5. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender. Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770 [TBL] [Abstract][Full Text] [Related]
8. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour]. Born PW; Broholm H; Laursen H Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240 [TBL] [Abstract][Full Text] [Related]
9. Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas. Qu M; Olofsson T; Sigurdardottir S; You C; Kalimo H; Nistér M; Smits A; Ren ZP Acta Neuropathol; 2007 Feb; 113(2):129-36. PubMed ID: 17031656 [TBL] [Abstract][Full Text] [Related]
10. Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas? Gadji M; Fortin D; Tsanaclis AM; Drouin R Cancer Genet Cytogenet; 2009 Oct; 194(1):12-22. PubMed ID: 19737649 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling. Tews B; Felsberg J; Hartmann C; Kunitz A; Hahn M; Toedt G; Neben K; Hummerich L; von Deimling A; Reifenberger G; Lichter P Int J Cancer; 2006 Aug; 119(4):792-800. PubMed ID: 16550607 [TBL] [Abstract][Full Text] [Related]
12. Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity. Franco-Hernández C; Martínez-Glez V; de Campos JM; Isla A; Vaquero J; Gutiérrez M; Casartelli C; Rey JA Cancer Genet Cytogenet; 2009 Apr; 190(2):93-6. PubMed ID: 19380026 [TBL] [Abstract][Full Text] [Related]
13. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors. Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553 [TBL] [Abstract][Full Text] [Related]
14. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p. Hashimoto N; Murakami M; Takahashi Y; Fujimoto M; Inazawa J; Mineura K Cancer; 2003 May; 97(9):2254-61. PubMed ID: 12712480 [TBL] [Abstract][Full Text] [Related]
15. Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors. Iuchi T; Namba H; Iwadate Y; Shishikura T; Kageyama H; Nakamura Y; Ohira M; Yamaura A; Osato K; Sakiyama S; Nakagawara A Genes Chromosomes Cancer; 2002 Oct; 35(2):170-5. PubMed ID: 12203781 [TBL] [Abstract][Full Text] [Related]
16. Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival. Felsberg J; Erkwoh A; Sabel MC; Kirsch L; Fimmers R; Blaschke B; Schlegel U; Schramm J; Wiestler OD; Reifenberger G Brain Pathol; 2004 Apr; 14(2):121-30. PubMed ID: 15193024 [TBL] [Abstract][Full Text] [Related]
17. Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis. Barbashina V; Salazar P; Ladanyi M; Rosenblum MK; Edgar MA Am J Surg Pathol; 2007 Aug; 31(8):1196-202. PubMed ID: 17667543 [TBL] [Abstract][Full Text] [Related]
18. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Kitange G; Misra A; Law M; Passe S; Kollmeyer TM; Maurer M; Ballman K; Feuerstein BG; Jenkins RB Genes Chromosomes Cancer; 2005 Jan; 42(1):68-77. PubMed ID: 15472895 [TBL] [Abstract][Full Text] [Related]
19. Molecular genetic evidence for subtypes of oligoastrocytomas. Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453 [TBL] [Abstract][Full Text] [Related]
20. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India. Jha P; Agarwal S; Pathak P; Srivastava A; Suri V; Sharma MC; Chosdol K; Srivastava T; Gupta D; Gupta A; Suri A; Sarkar C Cancer Genet Cytogenet; 2010 Apr; 198(2):126-34. PubMed ID: 20362227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]